International Raw Material Partners

Strategic collaborations with global industry leaders

BASF

Global Chemical Leader

Advanced excipients and pharmaceutical-grade raw materials for drug delivery systems. Collaboration on solubilizer technologies and sustainable material sourcing.

Gattefossé

Lipid Technology Specialist

Innovative lipid-based formulations and dermal delivery technologies. Strategic partnership for liposome formulation support and topical applications.

Lubrizol

Polymer Technology Leader

Advanced polymers for controlled release and specialty drug delivery systems. Collaboration on sustained release technologies and biocompatible materials.

Partnership Benefits

Premium Materials

Access to highest quality pharmaceutical ingredients

Innovation Access

Early access to cutting-edge technologies

Technical Support

Comprehensive development assistance

Regulatory Advantage

Pre-approved materials for faster market entry

Features

Strategic Partnership Model

 

A powerful 3-party synergy for global market success

Novoremedy USA

Technical & R&D Expertise

  • Formulation development
  • Quality assurance
  • US regulatory standards
  • Technical validation
  • Technology transfer
  • Scientific credibility

Your Company

Global Production Partner

  • GMP manufacturing
  • Quality control
  • Production scaling
  • Supply chain management
  • Product consistency
  • Cost efficiency

Quang Anh Vietnam

Market Access & Distribution

  • 32-province coverage
  • Regulatory approvals
  • Hospital networks
  • Marketing execution
  • VND 82B revenue
  • >20% annual growth

Why This Partnership Works

Partnership Value Proposition

 

Comprehensive benefits for international manufacturers

📈

Streamlined Market Entry

Leverage established infrastructure and relationships for rapid market penetration

  • Established distribution network across 32 provinces
  • Expedited regulatory approvals via local expertise
  • Pre-existing hospital and pharmacy partnerships (780+)
  • GDP-certified logistics already operational
  • Immediate market access with proven track record

💰

Growth Acceleration

Access high-growth market with established execution capabilities

  • Access to $8.7B Vietnam pharma market (2028)
  • 10.5% CAGR market growth (2023-2028)
  • Partner with >20% annual revenue growth
  • Top 10 bidding position in local market
  • VND 82B proven annual revenue capacity

🛡️

Comprehensive Risk Mitigation

Multi-layered protection systems to safeguard your investment

  • Dual-territory monitoring (US & Vietnam)
  • Robust pharmacovigilance & quality control
  • Anti-dumping & territory protection protocols
  • Financial guarantees & MOQ commitments
  • Legal framework with clear dispute resolution

🔬

Technical Excellence

US pharmaceutical standards combined with local market optimization

  • Scientific marketing & CME activities
  • Technical optimization & formulation support
  • US-based quality assurance protocols
  • FDA regulatory expertise applied locally
  • Continuous product improvement capabilities

The Novoremedy Advantage

“This 3-party model provides manufacturers a single coordinated partnership that combines US technical expertise with on-the-ground Vietnam market execution, reducing entry barriers by 70% while maximizing revenue potential in a fast-growing $8.7B market.”